Diferencia entre revisiones de «Pediatric fever of uncertain source»
(Created page with "<parsererror style="display: block; white-space: pre; border: 2px solid #c77; padding: 0 1em 0 1em; margin: 1em; background-color: #fdd; color: black"> === This page contains the...") |
Sin resumen de edición |
||
| Línea 1: | Línea 1: | ||
{| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%" | |||
=== | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | ||
! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Age Group | |||
=== | ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Evaluation | ||
! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Treatment | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | | |||
:'''Neonate, 0–28 d* of age, [[Image:]]38°C (100.4°F)''' | |||
:SBI incidence of ill appearing: 13%–21%; if not ill appearing: <5% | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | | |||
:CBC and blood culture. | |||
:''and'' | |||
:Urinalysis and urine culture. | |||
:''and'' | |||
:CSF cell count, Gram stain, and culture. | |||
:Chest x-ray is optional, if no respiratory symptoms. | |||
:Stool testing if diarrhea is present. | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | | |||
:Admit. | |||
:''and'' | |||
:Parenteral antibiotic therapy with ampicillin, 50 milligrams/kg, and cefotaxime, 50 milligrams/kg, or gentamicin, 2.5 milligrams/kg. | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | | |||
:'''Infant 29–56 d* of age, [[Image:]]38.2°C (100.8°F) (Philadelphia Protocol)''' | |||
:SBI incidence of ill appearing: 13%–21%; if not ill appearing: <5% | |||
< | |||
|- | | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Same as for neonates. | ||
| style="color: rgb(51, 51, 51); " | | | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | | ||
:Discharge if: | |||
| | :WBC [[Image:]]15,000/mm<sup>3</sup> and [[Image:]]5000/mm<sup>3</sup> and <20% band forms. | ||
: Urinalysis negative. | |||
: CSF WBC <10 cells/mm<sup>3</sup>. | |||
: Negative chest x-ray or fecal leukocytes if applicable. | |||
:Admit if any of above criteria are not met and treat with parenteral ceftriaxone, 50 milligrams/kg with normal CSF, 100 milligrams/kg with signs of meningitis. | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | | |||
:'''Infants 57 d* to 6 mo* of age, [[Image:]]38°C (100.4°F)''' | |||
:Non-UTI SBI incidence is estimated to be negligible | |||
:UTI is 3%–8% | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | | |||
:Urinalysis and urine culture alone. | |||
:''or'' | |||
:For conservative management, treat infants 57–90 d using Philadelphia Protocol above. | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | | |||
:Discharge if negative. | |||
:Treat for UTI with cefixime, 8 milligrams/kg/d daily or divided twice a day, or cefpodoxime, 10 milligrams/kg/d divided twice a day, or cefdinir, 14 milligrams/kg/d divided every 12–24 h for 7–10 d as outpatient. | |||
:Admit and treat with the parenteral ceftriaxone if fails conservative criteria for discharge. | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | | |||
:'''Infants 57 d to 6 mo* of age [[Image:]]39°C (102.2°F)''' | |||
:SBI incidence is estimated <1%; non-UTI SBI incidence is estimated to be negligible. | |||
:UTI is 3%–8% | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | | |||
:Urinalysis and urine culture alone. | |||
:''or'' | |||
:Urinalysis and urine culture in addition to CBC and blood culture. | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | | |||
:Discharge if negative. | |||
:Treat for UTI as above. | |||
:If WBC [[Image:]]15,000/mm<sup>3</sup>, consider treatment with ceftriaxone, 50 milligrams/kg IV/IM, and follow-up in 24 h. | |||
:If WBC [[Image:]]20,000/mm<sup>3</sup>, consider chest x-ray and CSF testing<sup>[[Image:]]</sup>. | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | | |||
:'''Infants/children 6–36 mo of age''' | |||
:Non-UTI SBI incidence is <0.4% | |||
:UTI in girls [[Image:]]8% | |||
:UTI in boys (<12 mo) [[Image:]]2% | |||
:Uncircumcised boys (1–2 y) remains 2% | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | | |||
:Urinalysis and urine culture. | |||
: Girls 6–24 mo. | |||
: Boys 6–12 mo. | |||
: Uncircumcised boys 12–24 mo. | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | | |||
:Discharge if negative. | |||
:Treat for UTI as above as outpatient. | |||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | '''Children >36 mo and older''' | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | No further workup is routinely necessary. | |||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Discharge and treat with acetaminophen, 15 milligrams/kg PO/PR every 4 h, or ibuprofen, 10 milligrams/kg PO every 6 h as needed. | |||
|} | |} | ||
Revisión del 00:44 14 jun 2011
| Age Group | Evaluation | Treatment |
|---|---|---|
|
|
|
|
Same as for neonates. |
|
|
|
|
|
|
|
|
|
|
| Children >36 mo and older | No further workup is routinely necessary. | Discharge and treat with acetaminophen, 15 milligrams/kg PO/PR every 4 h, or ibuprofen, 10 milligrams/kg PO every 6 h as needed. |
